Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Annals of Oncology

• Publication date

  2006-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ANNONC/MDJ108PMID 16357023
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ‘Chemobrain’ in breast carcinoma?

  2004cited by this paper
• Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study

  2004cited by this paper
• High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial.

  2004cited by this paper
• Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target

  2004cited by this paper
• The cognitive sequelae of standard‐dose adjuvant chemotherapy in women with breast carcinoma

  2004cited by this paper
• Biochemical and Clinical Aspects of Methotrexate Neurotoxicity

  2003cited by this paper
• Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literature

  2003cited by this paper
• The relationship of APOE genotype to neuropsychological performance in long‐term cancer survivors treated with standard dose chemotherapy

  2003cited by this paper
• Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.

  2003cited by this paper
• Cognitive dysfunction and chemotherapy: neuropsychological findings in perspective.

  2002cited by this paper
• Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients.

  2002influential reference
• Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

  2002cited by this paper
• Breast cancer chemotherapy-related cognitive dysfunction.

  2002cited by this paper
• Cognitive Effects of Standard-Dose Chemotherapy in Patients with Cancer

  2001cited by this paper
• Cognitive function after systemic therapy for breast cancer.

  2001cited by this paper
• Verbaler Lern- und Merkfähigkeitstest

  2001cited by this paper
• Lehrbuch der Klinischen Neuropsychologie. Grundlagen - Methoden - Diagnostik - Therapie: (1999). Lisse, NL: Swets & Zeitlinger, 860 Seiten, DM 148,-.

  2000cited by this paper
• Neurocognitive dysfunction in cancer patients.

  2000cited by this paper
• Cognitive function in breast cancer patients receiving adjuvant chemotherapy.

  2000cited by this paper
• Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma

  1999cited by this paper
• Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

  1998cited by this paper
• Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer

  1995cited by this paper
• Trail Making Test: Manual for Administration and Scoring

  1992cited by this paper
• The Adult Spine

  1991influential reference
• L’examen Clinique en Psychologie

  1959cited by this paper

• Chemotherapy induces multiple sclerosis-like neuropathologies that can be rescued by clobetasol.

  2025cites this paper
• Chemotherapy‐induced cognitive impairment in breast cancer survivors: A systematic review of studies from 2000 to 2021

  2024cites this paper
• Prevalence of cognitive impairment in patients receiving 5-fluoro-uracil containing chemotherapy: A systematic review and meta-analysis

  2024cites this paper
• Impact of nonpharmacological interventions on cognitive impairment in women with breast cancer: A systematic review and meta-analysis.

  2023cites this paper
• A scoping review of cognitive assessment tools and domains for chemotherapy-induced cognitive impairments in cancer survivors

  2023cites this paper
• Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions

  2022cites this paper
• Establishing construct validity of neuropsychological tests in cancer survivors

  2022cites this paper
• Chemo-Brain: An Activation Likelihood Estimation Meta-Analysis of Functional Magnetic Resonance Imaging Studies.

  2021cites this paper
• Chemotherapy-related cognitive impairment (CRCI) among early-stage breast cancer survivors in Malaysia

  2021cites this paper
• Effects of Adjuvant Chemotherapy on Cognitive Function of Patients With Early‐stage Colorectal Cancer

  2019cites this paper
• Chemotherapy-induced cognitive impairments: A systematic review of the animal literature.

  2019cites this paper
• Neuropsychological disorders in non-central nervous system cancer: a review of objective cognitive impairment, depression, and related rehabilitation options

  2019cites this paper
• Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: A multilevel meta‐analysis

  2017cites this paper
• Deterioro cognitivo inducido por la quimioterapia en pacientes diagnosticadas de cancer de mama

  2017cites this paper
• NONME-TASTATIC BREAST CANCER : A REVIEW

  2017cites this paper
• Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature

  2017cites this paper
• Evolution of Human Sex-Specific Cognitive Vulnerabilities

  2017cites this paper
• Executive functioning impairment in women treated with chemotherapy for breast cancer: a systematic review

  2017cites this paper
• High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer.

  2016cites this paper
• Brain structure and function in patients with ovarian cancer treated with first-line chemotherapy: a pilot study

  2016cites this paper
• Executive Functioning in Women with Breast Cancer: A Longitudinal Examination of Intraindividual Variability in Reaction Time

  2016influential citation
• Chemobrain – description of neuropsychological research methodology of cognitive dysfunctions after chemotherapy

  2016cites this paper
• The role of DNA damage and repair in toxicity to postmitotic cells caused by cancer therapies

  2016cites this paper
• Human Vulnerability for Brain and Cognitive Traits

  2015cites this paper
• Chemotherapy-induced cognitive changes

  2015cites this paper
• Objectively measured physical activity and cognitive functioning in breast cancer survivors

  2015cites this paper
• A Meta-Analysis of Cognitive Impairment and Decline Associated with Adjuvant Chemotherapy in Women with Breast Cancer

  2015cites this paper
• Potential Use of Nicotinic Receptor Agonists for the Treatment of Chemotherapy-Induced Cognitive Deficits

  2015cites this paper
• Retracted: Involvement of insulin-like growth factor-1 in chemotherapy-related cognitive impairment.

  2015cites this paper
• Chemo-Gehirn

  2015influential citation
• COGNITIVE DECLINE AMONG BREAST CANCER PATIENTS

  2015cites this paper
• Medical Disorders and Behavioral Risk Factors

  2014cites this paper
• Cognitive function in women with breast cancer receiving adjuvant chemotherapy and healthy controls

  2014cites this paper
• [Aspects of encephalopathy in oncologic patients after chemotherapy].

  2014cites this paper
• Chemo-Gehirn

  2014influential citation
• Neurocognitive Effects of Cancer: A New Surrogate End Point

  2014cites this paper
• Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia.

  2013cites this paper
• Does chemotherapy lead to a visual search deficit

  2013cites this paper
• Opening up the Window into “Chemobrain”: A Neuroimaging Review

  2013cites this paper
• The effect of systemic chemotherapy on neurogenesis, plasticity and memory.

  2013cites this paper
• Cognitive effects of chemotherapy in breast cancer patients: a dose–response study

  2013cites this paper
• Chemotherapy Induced Deficits in Cognition and Affective Behavior

  2013cites this paper
• Cognitive features 10 or more years after successful breast cancer survival: comparisons across types of cancer interventions

  2013cites this paper
• Les fonctions cognitives au commencement d’une nouvelle ligne de traitement chez des patients âgés atteints d’un cancer hématologique

  2013cites this paper
• Pharmacogenetics of Apolipoprotein E on Donepezil and Fluoxetine Pharmacotherapy for Chemotherapeutic Induced Neurocognitive Decline

  2013cites this paper
• Cognitive function and quality of life in ovarian cancer.

  2012cites this paper
• The influence of adjuvant chemotherapy on cognitive functioning of women with breast cancer: a literature review

  2012cites this paper
• Chemotherapy-Related Cognitive Dysfunction

  2012cites this paper
• Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.

  2012cites this paper
• Why, After Chemotherapy, is it Necessary to Assess Memory Using Translational Testing?

  2012cites this paper
• Neuro-cognitive impairment in breast cancer patients: pharmacological considerations.

  2012cites this paper
• An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors

  2012cites this paper
• Late effects of adjuvant chemotherapy on brain function and structure

  2012influential citation
• Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: A functional magnetic resonance imaging study

  2012cites this paper
• Structural Brain Differences in Breast Cancer Patients Compared to Matched Controls Prior to Chemotherapy

  2012cites this paper
• Preserved learning and memory in mice following chemotherapy: 5-Fluorouracil and doxorubicin single agent treatment, doxorubicin-cyclophosphamide combination treatment.

  2012cites this paper
• The Role of DNA Damage and Repair in Neurotoxicity Caused by Cancer Therapies

  2012cites this paper
• Efeitos Cognitivos da quimioterapia.

  2012cites this paper
• Chemotherapy-related cognitive impairment: the breast cancer experience.

  2012cites this paper
• Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.

  2012cites this paper
• The effect of 5-fluorouracil on the long term survival and proliferation of cells in the rat hippocampus.

  2012cites this paper
• Chemotherapy and Cognitive Impairment: Treatment Options

  2011cites this paper
• Cognitive dysfunction and cancer: which consequences in terms of disease management?

  2011influential citation
• Chemotherapy-induced cognitive impairment is associated with decreases in cell proliferation and histone modifications

  2011cites this paper
• Pre-Chemotherapy Differences in Visuospatial Working Memory in Breast Cancer Patients Compared to Controls: An fMRI Study

  2011cites this paper
• Preserved learning and memory following 5-fluorouracil and cyclophosphamide treatment in rats.

  2011cites this paper
• Chemotherapy effects on brain glucose metabolism at rest

  2011cites this paper
• International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer.

  2011cites this paper
• Psychosoziale Probleme von Langzeitüberlebenden einer Krebserkrankung

  2011cites this paper
• Analysis of Memory Deficits Following Chemotherapy in Breast Cancer Survivors: Evidence from the Doors and People Test

  2011cites this paper
• Rehabilitation of therapy-related cognitive deficits in patients with breast cancer

  2011influential citation
• A Quantitative Analysis of Cognitive Impairments Following Breast Cancer Treatment

  2011cites this paper
• The relationship between social support, optimism, and cognition in breast cancer and non-Hodgkin's lymphoma survivors

  2011influential citation
• What Happens Before Chemotherapy?! Neuro-anatomical and -functional MRI Investigations of the Pre-chemotherapy Breast Cancer Brain.

  2011cites this paper
• 43 – Cognitive function in cancer survivors

  2011cites this paper
• Effect of 5-fluorouracil chemotherapy and the potential protective effect of the SSRI antidepressant fluoxetine on memory and neurogenesis in the adult hippocampus

  2010cites this paper
• Is systemic anti-cancer therapy neurotoxic? Does chemo brain exist? And should we rename it?

  2010cites this paper
• Bayesian models for longitudinal data

  2010cites this paper
• Cognitive functions in long-term survivors of ovarian cancer.

  2010cites this paper
• Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release.

  2010cites this paper
• Fluoxetine improves the memory deficits caused by the chemotherapy agent 5-fluorouracil.

  2010cites this paper
• Short introduction and history.

  2010cites this paper
• Effects of 5-FU.

  2010cites this paper
• Effects of Specific Neuropsychological Training Programs for Breast Cancer Patients After Adjuvant Chemotherapy

  2009influential citation
• Measuring neuropsychological change following breast cancer treatment: An analysis of statistical models

  2009cites this paper
• High-dose chemotherapy for high-risk primary and metastatic breast cancer: is another look warranted?

  2009cites this paper
• Prophylactic cranial irradiation in advanced breast cancer: a case for caution.

  2009cites this paper
• Deterioro cognitivo inducido por los tratamientos oncológicos sistémicos en el cáncer de mama no metastático: revisión de estudios

  2009cites this paper
• Cognitive function in breast cancer survivors.

  2009cites this paper
• Stehen kognitive Funktionen im Zusammenhang mit Angst, Depression und Posttraumatischer Belastungsstörung bei Brustkrebspatientinnen nach onkologischer Behandlung?

  2009cites this paper
• Breast Cancer Treatment and Cognitive Function: The Current State of Evidence, Underlying Mechanisms and Potential Treatments

  2009cites this paper
• Predictors of Cognitive Decline After Chemotherapy in Breast Cancer Patients

  2009cites this paper
• [Cognitive impairments and breast cancer: a critical review of the literature].

  2009cites this paper
• Cognitive effects of chemotherapy in post‐menopausal breast cancer patients 1 year after treatment

  2009cites this paper
• Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study

  2009cites this paper
• Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer

  2009cites this paper
• KAPITEL 15 – Chemobrain? – Kognitive Störungen nach Chemotherapie

  2009cites this paper
• Long-term effects of imatinib on cognition in chronic myeloid leukaemia

  2009cites this paper
• Association between structural measures of specific regional brain volumes measured by quantitative magnetic resonance imaging and neurocognitive performance in elderly breast cancer survivors exposed to chemotherapy

  2009cites this paper
• Neurocognitive effects of chemotherapy in adults

  2008cites this paper